Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Culwell Kelly Create: Alert

All | News | Filings
Date FiledTypeDescription
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 200,000 shares @ $0
Granted 150,000 options to buy @ $3.25, valued at $487.5k
06/08/2020 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 31,548 shares @ $3.31, valued at $104.4k
05/26/2020 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 39,435 shares @ $4.99, valued at $196.8k
05/08/2020 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 7,792 shares @ $5.24, valued at $40.8k
05/01/2020 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Sold 1,000 shares @ $4.66, valued at $4.7k
Sold 1,000 shares @ $4.75, valued at $4.8k
02/21/2020 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Sold 1,000 shares @ $7, valued at $7k
02/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/04/2019 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Sold 1,000 shares @ $7.35, valued at $7.4k
11/26/2019 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 5,187 shares @ $6.22, valued at $32.3k
11/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2019 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 864 shares @ $5.13, valued at $4.4k
06/12/2019 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 5,187 shares @ $6.36, valued at $33k
04/03/2019 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 1,022 shares @ $3.55, valued at $3.6k
11/29/2018 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted options to buy @ $3.45, valued at $0
08/20/2018 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 3,000 shares @ $2.24, valued at $6.7k
07/03/2018 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 13,733 shares @ $0
Paid exercise price by delivering 4,748 shares @ $2.46, valued at $11.7k
03/14/2018 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 260,000 options to buy @ $7.29, valued at $1.9M
01/18/2018 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 7,699 options to buy @ $46.36, valued at $356.9k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy